Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novocure Ltd Ord Sh (NQ: NVCR )

16.31 +0.13 (+0.80%)
Streaming Delayed Price Updated: 2:59 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novocure Ltd Ord Sh

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Cancer Therapy Novocure Stock Still On A High As It Clears Technical Benchmark
Cancer therapy Novocure stock had its Relative Strength (RS) Rating upgraded from 90 to 93 Wednesday. It's also an IBD 50 member. 
Via Investor's Business Daily
Is Novocure a Buy?
Once a stock goes up 50% in a single day, it can be hard to keep the momentum going. 
Via The Motley Fool
Why Investors Are So Excited About Novocure
The company's Tumor Treating Fields therapy looks very promising in treating lung cancer. 
Via The Motley Fool
Currency Manipulation
London's FTSE 100 index today rose over 7000 for the first time in 14 months. It hit 7019.53. 
Via Talk Markets
Stock Market Rally Keeps Rising As Treasury Yields Fall Despite Strong Earnings, Economic Data; Goldman, Nvidia, Coinbase In Focus
Tumbling yields and strong economic data fueled stocks. Goldman earnings, Nvidia news and the Coinbase IPO were in focus. 
Via Investor's Business Daily
Topics Initial Public Offering Stocks
Exposures Securities Market US Equities
This Stock Just Popped 40%. Here's Why It Can Continue to Crush the Market
Novocure has provided stellar returns over the last five years, now up 17 times. Recent positive news may keep its stock going up. 
Via The Motley Fool
Happy News Day
The stock markets are in clover because March retail sales hit 9.8% according to the Department of Commerce. 
Via Talk Markets
Stunning Market Debut
Wednesday brought a zip into the accounts of many financial stocks thanks to a boom result from Goldman Sachs GS, which boosted its competitors' prices. 
Via Talk Markets
Cancer Therapy Novocure Stock Flashes Renewed Technical Strength
Novocure stock saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 67 to 92. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Akumin (NASDAQ:AKU) shares increased by 13.54% to $3.52 during Wednesday's pre-market session. The market value of their outstanding shares is at $247.0... 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
JP Morgan raised Southwest Airlines Co. (NYSE: LUV) price target from $44 to $66. Southwest Airlines shares rose 1% to $63.79 in pre-market trading. Keybanc boosted Public... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2021
Upgrades For Cardlytics Inc (NASDAQ:CDLX), Craig-Hallum upgraded the previous rating of Hold to Buy. For the fourth quarter, Cardlytics had an EPS of $0.05, compared to... 
Via Benzinga
Electric Cancer Cure
Most US stocks were down on fear of inflation and financial risks but then rose after lunch. 
Via Talk Markets
The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 13) Bio-Techne Corporation (... 
Via Benzinga
Exposures Product Safety
Why Novocure Stock Skyrocketed Today
The oncology specialist's investigational cancer treatment could be a game-changer. 
Via The Motley Fool
50 Biggest Movers From Yesterday
Gainers Mackinac Financial Corporation (NASDAQ: MFNC) shares surged 60.7% to close at $21.16 on Tuesday after the company, and Nicolet Bankshares, jointly announced the execution... 
Via Benzinga
Mid-Afternoon Market Update: Dow Falls 75 Points; vTv Therapeutics Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded down 0.22% to 33,669.76 while the NASDAQ rose 0.80% to 13,960.92. The S&P also rose, gaining 0.28% to 4,139.55. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
What's Going On With NVCR Stock And VTV Stock Today?
Novocure Ltd (NASDAQ: NVCR) shares are trading higher after a data monitoring committee said the interim analysis of the company's Phase 3 LUNAR trial would be accelerated.... 
Via Benzinga
Stocks Mixed Following JNJ Vaccine Update, Inflation Data
The Dow is off more than 100 points. The S&P 500 notched a new intraday high. 
Via Talk Markets
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers NovoCure (NASDAQ:NVCR) shares rose 42.08% to $187.38 during Tuesday's regular session. Trading volume for NovoCure's stock is 11.4 million as of 12:32 EST... 
Via Benzinga
Independent Monitors Suggest Shorter Timeline for Novocure's Lung Cancer Treatment
A trial examining the use of Novocure's tumor-treating field technology in non-small cell lung cancer patients could enroll fewer patients over a shorter period, based on recommendations by an... 
Via The Motley Fool
Mid-Day Market Update: Nasdaq Jumps 100 Points; Avenue Therapeutics Shares Slide
Midway through trading Tuesday, the Dow traded down 0.34% to 33,630.52 while the NASDAQ rose 0.75% to 13,953.54. The S&P also rose, gaining 0.12% to 4,133.03. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers Mackinac Financial Corporation (NASDAQ: MFNC) jumped 57.6% to $20.75 after the company, and Nicolet Bankshares, jointly announced the execution of a definitive merger... 
Via Benzinga
NVCR Stock: The Cancer Therapy News That Has Novocure Shares Skyrocketing Today
NVCR stock is skyrocketing on Tuesday after cancer treatment firm Novocure received great news regarding its phase 3 tumor treatment trial. 
Via InvestorPlace
Mid-Morning Market Update: Markets Mixed; Fastenal Profit Tops Estimates
Following the market opening Tuesday, the Dow traded down 0.39% to 33,615.29 while the NASDAQ rose 0.70% to 13,946.14. The S&P also rose, gaining 0.11% to 4,132.39. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Stocks That Hit 52-Week Highs On Tuesday
This morning 106 companies set new 52-week highs. Interesting Highlights: Microsoft (NASDAQ:MSFT) was the largest company by market cap to set a new 52-week high... 
Via Benzinga
Novocure Stock Rockets As Experts Recommend Accelerating Cancer Study
A board gave Novocure the go-ahead on Tuesday to recruit fewer patients for a study in lung-cancer treatment. The news sent NVCR stock rocketing. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers NovoCure (NASDAQ:NVCR) shares rose 63.02% to $215.0 during Tuesday's pre-market session. The company's market cap stands at $22.0 billion. Axcella Health (... 
Via Benzinga
Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer
From Novocure
Via Business Wire
Novocure Announces 26 Presentations at American Association for Cancer Research (AACR) Annual Meeting 2021 Suggesting Broad Applicability of Tumor Treating Fields
From Novocure
Via Business Wire
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.